FI118472B - Autoantigeenistä johdettuja uusia peptidejä autoimmuunitautien immunoterapiassa käyttöä varten - Google Patents

Autoantigeenistä johdettuja uusia peptidejä autoimmuunitautien immunoterapiassa käyttöä varten Download PDF

Info

Publication number
FI118472B
FI118472B FI962619A FI962619A FI118472B FI 118472 B FI118472 B FI 118472B FI 962619 A FI962619 A FI 962619A FI 962619 A FI962619 A FI 962619A FI 118472 B FI118472 B FI 118472B
Authority
FI
Finland
Prior art keywords
seq
peptides
peptide
amino acid
cells
Prior art date
Application number
FI962619A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI962619A (fi
FI962619A0 (fi
Inventor
Anna Maria Helena Boots
Gijsbertus Francisc Verheijden
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of FI962619A publication Critical patent/FI962619A/fi
Publication of FI962619A0 publication Critical patent/FI962619A0/fi
Application granted granted Critical
Publication of FI118472B publication Critical patent/FI118472B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Rehabilitation Therapy (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI962619A 1994-10-27 1996-06-25 Autoantigeenistä johdettuja uusia peptidejä autoimmuunitautien immunoterapiassa käyttöä varten FI118472B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP94203128 1994-10-27
EP94203128 1994-10-27
EP95200886 1995-04-07
EP95200886 1995-04-07
EP9504201 1995-10-25
PCT/EP1995/004201 WO1996013517A1 (fr) 1994-10-27 1995-10-25 Nouveaux peptides derives d'un autoantigene et destines a l'immunotherapie des maladies auto-immunes

Publications (3)

Publication Number Publication Date
FI962619A FI962619A (fi) 1996-06-25
FI962619A0 FI962619A0 (fi) 1996-06-25
FI118472B true FI118472B (fi) 2007-11-30

Family

ID=26136688

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962619A FI118472B (fi) 1994-10-27 1996-06-25 Autoantigeenistä johdettuja uusia peptidejä autoimmuunitautien immunoterapiassa käyttöä varten

Country Status (24)

Country Link
US (1) US5736507A (fr)
EP (1) EP0733065B1 (fr)
JP (1) JP3755894B2 (fr)
KR (1) KR100485979B1 (fr)
CN (1) CN1161379C (fr)
AT (1) ATE177756T1 (fr)
AU (1) AU696827B2 (fr)
BR (1) BR9506377A (fr)
CA (1) CA2173874A1 (fr)
DE (1) DE69508380T2 (fr)
DK (1) DK0733065T3 (fr)
ES (1) ES2130672T3 (fr)
FI (1) FI118472B (fr)
GR (1) GR3030296T3 (fr)
HK (1) HK1002012A1 (fr)
HU (1) HU218027B (fr)
IL (1) IL115744A (fr)
MX (1) MX9602495A (fr)
NO (1) NO316703B1 (fr)
NZ (1) NZ295659A (fr)
PL (1) PL183761B1 (fr)
RU (1) RU2178797C2 (fr)
TR (1) TR199501326A2 (fr)
WO (1) WO1996013517A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843449A (en) * 1996-03-25 1998-12-01 Akzo Nobel N.V. Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
US6881824B1 (en) 1996-04-24 2005-04-19 Akzo Nobel N.V. Peptides suitable for use in antigen specific immunosuppressive therapy
IL120561A0 (en) 1996-04-24 1997-07-13 Akzo Nobel Nv Peptides suitable for use in immunosuppressive therapy
EP0947524A1 (fr) * 1998-03-30 1999-10-06 Upither B.V. Nouveaux peptides destinés au traitement de maladies auto-immunes
EP1100526A2 (fr) * 1998-07-23 2001-05-23 Akzo Nobel N.V. UTILISATION DE gp-39 DE CARTILAGE HUMAIN DANS DES MALADIES IMMUNES
KR20010071020A (ko) * 1998-07-23 2001-07-28 에프.지.엠. 헤르만스 ; 이.에이치. 리링크 자가 면역 질환의 면역 요법에서 사용하기 위한 신규한펩티드
AU780238B2 (en) * 1999-10-18 2005-03-10 Akzo Nobel N.V. Modified peptides and peptidomimetics for use in immunotherapy
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
HUP0400659A3 (en) * 2001-07-24 2005-06-28 Zhu Zhou Woodbridge Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
WO2005081980A2 (fr) * 2004-02-25 2005-09-09 Medimmune, Inc. Methodes et compositions relatives aux chitinases et aux molecules du type chitinase et modulation des osteoclastes
WO2007027748A2 (fr) * 2005-08-31 2007-03-08 Medimmune, Inc. Antagonistes de c/clp et leurs methodes d'utilisation
RU2302872C9 (ru) * 2006-06-22 2008-12-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Средство, нормализующее функции хрящевой ткани, и способ его получения
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
CA2696563A1 (fr) 2007-08-15 2009-02-19 Circassia Limited Peptides pour vaccin
EP2153841B2 (fr) 2008-08-15 2015-11-11 Circassia Limited Vaccin comprenant des peptides de Amb a 1 pour le traitement de l'allergie des ambroisies
EP2331124A1 (fr) * 2008-08-15 2011-06-15 Circassia Limited Peptide de l antigène des cellules t d allergène destiné à stimuler la production d il-10
GB2469894B (en) 2009-02-05 2011-09-07 Circassia Ltd Peptides for use in treating allergy to grass pollen
CA2778669C (fr) * 2009-10-27 2019-04-16 Erytech Pharma Composition induisant une tolerance immunitaire specifique
EP3344575B1 (fr) 2015-09-04 2020-04-15 SQZ Biotechnologies Company Administration intracellulaire de biomolécules à des cellules comprenant une paroi cellulaire

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6323898A (ja) * 1986-07-16 1988-02-01 Dainippon Pharmaceut Co Ltd 新規ポリペプチド及びそれをコ−ドするｄｎａ並びにそれらの製法
IL92629A0 (en) * 1989-12-10 1990-08-31 Yeda Res & Dev Direct binding of t-cell epitopes to mhc gene products on intact living antigen presenting cells and the use thereof for identifying epitopes causing autoimmune diseases and pharmaceutical compositions for treating such diseases
CA2164498C (fr) * 1993-07-09 2007-09-11 Paul A. Price Essai pour ykl-40 comme marqueur de la degradation des constituants du tissu conjonctif de mammiferes

Also Published As

Publication number Publication date
HK1002012A1 (en) 1998-07-24
TR199501326A2 (tr) 1996-06-21
DE69508380T2 (de) 1999-09-09
KR100485979B1 (ko) 2006-01-27
NZ295659A (en) 1998-02-26
US5736507A (en) 1998-04-07
WO1996013517A1 (fr) 1996-05-09
DK0733065T3 (da) 1999-10-11
RU2178797C2 (ru) 2002-01-27
IL115744A (en) 2000-07-16
JPH09507861A (ja) 1997-08-12
FI962619A (fi) 1996-06-25
PL183761B1 (pl) 2002-07-31
HUT74847A (en) 1997-02-28
IL115744A0 (en) 1996-01-19
ES2130672T3 (es) 1999-07-01
GR3030296T3 (en) 1999-09-30
MX9602495A (es) 1997-05-31
AU3925295A (en) 1996-05-23
BR9506377A (pt) 1997-09-16
HU218027B (hu) 2000-05-28
PL315198A1 (en) 1996-10-14
DE69508380D1 (de) 1999-04-22
AU696827B2 (en) 1998-09-17
HU9601401D0 (en) 1996-07-29
CN1161379C (zh) 2004-08-11
NO962695L (no) 1996-06-26
CA2173874A1 (fr) 1996-05-09
CN1168677A (zh) 1997-12-24
NO316703B1 (no) 2004-04-13
FI962619A0 (fi) 1996-06-25
NO962695D0 (no) 1996-06-26
KR960705848A (ko) 1996-11-08
EP0733065B1 (fr) 1999-03-17
ATE177756T1 (de) 1999-04-15
EP0733065A1 (fr) 1996-09-25
JP3755894B2 (ja) 2006-03-15

Similar Documents

Publication Publication Date Title
FI118472B (fi) Autoantigeenistä johdettuja uusia peptidejä autoimmuunitautien immunoterapiassa käyttöä varten
US5843449A (en) Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
Goyert et al. Isolation of I–A subregion-like molecules from subhuman primates and man
JP4794102B2 (ja) フィブリンのシトルリン誘導体及び慢性関節リウマチの診断又は治療のためのその使用
RU2199548C2 (ru) Новые пептиды, которые могут быть использованы в антиген-специфической иммуносупрессорной терапии
Krco et al. Characterization of the antigenic structure of human type II collagen.
Misaki et al. B cell epitope on the U1 snRNP‐C autoantigen contains a sequence similar to that of the herpes simplex virus protein
KR100769338B1 (ko) 류마티스성 관절염（ｒａ） 항원성 펩타이드
CA2187299A1 (fr) Peptide de noyau du virus de l'hepatite c pour la stimulation des lymphocytes t cytotoxiques et le diagnostic de l'exposition au vhc
IE74168B1 (en) Genes coding for a protein having human MACIF activity expression vectors containing said genes transformant cells and proteins having human MACIF activity
JP5999703B2 (ja) ＨＬＡ−ＤＲ１拘束性Ｔａｘ特異的ＣＤ４＋Ｔ細胞エピトープ
Rees et al. The effect of lipoylation on CD4 T-cell recognition of the 19,000 MW Mycobacterium tuberculosis antigen.
EP0833842B1 (fr) Nouveaux peptides utilises dans le traitement de la destruction du cartilage induite par les lymphocytes t dans les maladies auto-immunitaires
AU1906592A (en) Peptides for use in induction of t cell activation against hiv-1
US20040022777A1 (en) Fragments and antagonists of heat shock protein 60
KR20010071020A (ko) 자가 면역 질환의 면역 요법에서 사용하기 위한 신규한펩티드
US20020177554A1 (en) Novel peptides for use in treatment of T-cell mediated cartilage destruction in autoimmune diseases
MXPA98008866A (en) Novedosos peptidos suitable for use in antig specific immunosuppressive therapy

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: N.V. ORGANON

Free format text: N.V. ORGANON

FG Patent granted

Ref document number: 118472

Country of ref document: FI